Ledger.Open graph →
SEC Form D · Amendment · filed January 29, 2010

ALIOS BIOPHARMA INC

Offering
$34.2M
Sold
$30.2M
Exemption
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type

People & firms on this filing (12)

Peter Hirth · South San Francisco, CADirectorJack Nielsen · South San Francisco, CADirectorLeonid Beigelman · South San Francisco, CAExecCampbell Murray · South San Francisco, CADirectorLawrence Blatt · South San Francisco, CAExec · DirectorKent Gossett · South San Francisco, CADirectorSimon Ridgway · Vancouver, British Columbia, CanadaExec · DirectorMario Szotlender · Vancouver, British Columbia, CanadaExecInvestment Manager Bny Mellon, N.A · Pittsburgh, PADirectorCharles A. Warden · Menlo Park, CADirectorDiane Dewbrey · Bellevue, WADirectorFrederick W. Telling · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗